eleva Information

Eleva Biologics is a strategic partner for the discovery and development of highly complex biologics. Our proprietary moss-based Bryotechnology platform unlocks therapeutic proteins that are otherwise difficult or impossible to manufacture, including recombinant antibody modalities, multi-domain fusions, and other complex proteins. It offers precise control over glycosylation, ensures homogeneous production of complex proteins with correct folding and assembly, and integrates seamlessly into standard infrastructure. Our platform has produced two moss-derived candidates that have advanced into clinical development: a first-in-class, full-length recombinant human Factor H and a highly differentiated α-galactosidase.